Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery Company also announces key accreditations in recognition of excellence in data security,
Bio-Rad extends range of Vericheck ddPCR Empty-Full Capsid Kits to optimize AAV Vector Characterization
New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid Titer, Supporting Reliable Assessment of AAV Vector Quality
FUJIFILM Irvine Scientific sells its medical media business to Astorg
Singular focus on life sciences will accelerate the strategic growth of the company and expansion of its products and services to the market
Metrion Biosciences listed in The Sunday Times 100 Tech, as one of Britain's fastest-growing private technology companies
Inaugural feature recognises companies within the UK technology sector, developing or selling a proprietary technology Listing is recognition of Metrion’s leadership position in preclinical ion channel drug discovery research servicesCambr
Bio-Rad launches Nuvia wPrime 2A media for biomolecule purification
Scalable Weak Anion Exchange and Hydrophobic Interaction (AEX-HIC) Mixed-Mode Chromatography Resin Enables Small- to Large-Scale Purification for Research and Biotherapeutic Applications
Sapio Sciences announces enhanced capabilities for chemistry, immunogenicity, GMP and molecular biology
Sapio Lab Informatics Platform (Release 24.12) further optimizes productivity across lab workflows
Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers
Turnkey solution helps simplify and scale T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System, easing the burden for developers
Enhanc3D Genomics launches suite of 3D multi-omics solutions to accelerate drug development
Solutions driven by proprietary, integrated multi-omics platform to support data-driven, faster and more precise drug discovery and development, to be introduced during JPM Week Provides customers with access to Enhanced’s 3D genomics technology and 3D Multi-Omic P
Pheno Therapeutics granted clinical trial authorisation for lead multiple sclerosis therapeutic candidate PTD802
UK MHRA grants CTA for first-in-human trial of a selective GPR17 antagonist Small molecule therapeutic designed for treatment of neurological diseases such as multiple sclerosisEdinburgh, UK, 14 January 2025: Pheno Therapeutics Li
4basebio appoints Gabe Longoria as Chief Commercial Officer
Cambridge, UK, 09 January 2025 - 4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced the appointment of Gabe Long
Geneoscopy closes $105M in Series C funding round to power next-generation of gastrointestinal diagnostic tests
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease
Bio-Rad extends range of Foresight Pro prepacked chromatography columns for biotherapeutic production
Foresight Pro 45 cm ID Column Provides a Convenient and Reliable Solution for Purification of Biomolecules in Downstream Bioprocessing
Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring
Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients Findings support the use of the Company’s combined drug + digital approach to inform and
Bio-Rad receives NF validation for iQ-Check Listeria spp. and iQ-Check Listeria monocytogenes shortened enrichment protocol in all food products and environmental samples
HERCULES, Calif. — December 16, — 2024 Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, announces that NF Validation (AFNOR) has approved the extension of certification of the iQ-Check™ Listeria spp.
FairJourney Biologics establishes Scientific Advisory Board
Global industry leaders appointed to define key avenues for growth, accelerate innovation, and optimize scientific strategies to maintain leadership in antibody discovery and development
Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company
Combines Deep Science Ventures’ novel first-principles methodology and AI tools, with General Inception’s expertise in advancing early-stage innovations to drive scientific discovery and venture creation
Accelerating Innovation in Research and Diagnostics with Science-Aware AI
SapioCon 2025 speaker line-up highlights AI's role in reshaping the lab of the future
Newcells Biotech raises additional funding from investors
Newcastle, UK, 5th December 2024: Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, announces it has raised a furt
FairJourney Biologics appoints Dr. Marc van Dijk as Chief Scientific Officer of Antibody Discovery and Engineering
Appointment of industry expert to drive innovation and excellence in antibody discovery and engineering, to support market demand from global pharma and biotech
evitria Partners with Sapio Sciences to streamline antibody workflow management and reporting
Leading antibody expression service provider implements Sapio’s ELN and Report Builder for advanced sample tracking and data management
Orbit Discovery and Evergreen Theragnostics expand research collaboration to advance targeted therapeutics development
Oxford, UK, and Springfield, NJ, USA, 3rd December 2024: Orbit Discovery, a leading provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company at the forefront of precision medicine, today announced an extension to their research
Centauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives
Funding to support further development of lead programme for a novel therapeutic targeting Gram-negative bacteria including Multi-Drug-Resistant strains Optimisation will also support application of the Alphamer® platform across other therapeutic indicat
Metrion Biosciences appoints Lee Patterson as CEO
Significant CRO C-suite experience expected to drive growth and commercial expansion into global marketsCambridge, UK, 25 November 2024: Metrion Biosciences, the specialist preclinical contract research organisation (CRO) and a leader in ion channe
Shining a light on the life sciences
The OBN Awards struck an optimistic tone as the best of the UK’s life sciences industry was celebrated
